S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
Senate rules referee weakens Dem drug plan in economic bill
Dems push Biden climate, health priorities toward Senate OK
China July exports rise, with trade surplus at record-high
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
Senate rules referee weakens Dem drug plan in economic bill
Dems push Biden climate, health priorities toward Senate OK
China July exports rise, with trade surplus at record-high
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
Senate rules referee weakens Dem drug plan in economic bill
Dems push Biden climate, health priorities toward Senate OK
China July exports rise, with trade surplus at record-high
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
Senate rules referee weakens Dem drug plan in economic bill
Dems push Biden climate, health priorities toward Senate OK
China July exports rise, with trade surplus at record-high
NYSE:CLB

Core Laboratories (CLB) Stock Forecast, Price & News

$16.35
+0.07 (+0.43%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.11
$16.89
50-Day Range
$15.40
$31.02
52-Week Range
$15.21
$35.83
Volume
567,114 shs
Average Volume
464,964 shs
Market Capitalization
$757.50 million
P/E Ratio
86.06
Dividend Yield
0.24%
Price Target
$23.33

Core Laboratories MarketRank™ Forecast

Analyst Rating
Reduce
1.33 Rating Score
Upside/​Downside
42.7% Upside
$23.33 Price Target
Short Interest
Bearish
11.22% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.05mentions of Core Laboratories in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
82.14%
From $0.56 to $1.02 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Oils/Energy Sector

111th out of 336 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

14th out of 29 stocks

Core Laboratories logo

About Core Laboratories (NYSE:CLB) Stock

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Core Laboratories Stock Up 0.4 %

NYSE:CLB traded up $0.07 during trading on Friday, hitting $16.35. The stock had a trading volume of 567,114 shares, compared to its average volume of 464,964. Core Laboratories has a 12 month low of $15.21 and a 12 month high of $35.83. The company has a market capitalization of $757.50 million, a PE ratio of 86.06, a P/E/G ratio of 0.71 and a beta of 2.59. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.53 and a current ratio of 2.08. The company's 50-day moving average price is $20.76 and its two-hundred day moving average price is $25.66.

Core Laboratories (NYSE:CLB - Get Rating) last posted its earnings results on Wednesday, July 27th. The oil and gas company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by ($0.02). Core Laboratories had a return on equity of 16.12% and a net margin of 1.82%. The business had revenue of $120.90 million for the quarter, compared to analyst estimates of $121.35 million. During the same period in the previous year, the firm posted $0.18 earnings per share. The firm's revenue was up 1.8% compared to the same quarter last year. As a group, sell-side analysts forecast that Core Laboratories will post 0.56 EPS for the current year.

Core Laboratories Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 29th. Investors of record on Monday, August 8th will be given a dividend of $0.01 per share. The ex-dividend date is Friday, August 5th. This represents a $0.04 annualized dividend and a dividend yield of 0.24%. Core Laboratories's dividend payout ratio is currently 21.05%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Morgan Stanley reduced their price target on shares of Core Laboratories from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, August 1st. StockNews.com raised Core Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 11th. Stifel Nicolaus reduced their target price on Core Laboratories from $26.00 to $20.00 in a research report on Tuesday, July 26th. Finally, Piper Sandler cut Core Laboratories from a "neutral" rating to an "underweight" rating and lifted their price objective for the company from $19.50 to $21.30 in a report on Monday, April 18th.

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

SLB or CLB: Which Is the Better Value Stock Right Now?
Core Laboratories goes ex-dividend tomorrow
Why Energy Stocks Dropped on Monday
Core Laboratories (CLB) Q2 Earnings Match Estimates
Core Laboratories (NYSE:CLB) Shares Gap Down to $17.66
Why Shares in Core Labs Fell Today
Why Core Labs Stock Dived by More Than 10% Today
See More Headlines

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Company Calendar

Ex-Dividend for 5/31 Dividend
5/06/2022
Dividend Payable
5/31/2022
Last Earnings
7/27/2022
Ex-Dividend for 8/29 Dividend
8/05/2022
Today
8/07/2022
Dividend Payable
8/29/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,700
Year Founded
1936

Price Target and Rating

Average Stock Price Forecast
$23.33
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+42.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

Net Income
$19.73 million
Pretax Margin
4.48%

Debt

Sales & Book Value

Annual Sales
$470.25 million
Cash Flow
$1.12 per share
Book Value
$3.75 per share

Miscellaneous

Free Float
46,130,000
Market Cap
$757.50 million
Optionable
Optionable
Beta
2.59

Social Links


Key Executives

  • Mr. Lawrence V. Bruno (Age 62)
    Chairman, CEO, Pres & COO
    Comp: $1.61M
  • Mr. Christopher Scott Hill (Age 52)
    Sr. VP & CFO
    Comp: $702.65k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 54)
    Sr. VP of Corp. Devel. & Investor Relations
    Comp: $612.71k
  • Mr. Mark Damian Tattoli (Age 50)
    Sr. VP, Sec. & Gen. Counsel
    Comp: $948.9k
  • Mr. Kevin G. Daniels (Age 58)
    Chief Accounting Officer, Treasurer & VP
  • Mr. Jacobus Schouten (Age 67)
    Managing Director
  • J. Donald Dumas Jr.
    Sr. VP of Production Enhancement & Bus. Devel.













CLB Stock - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" Core Laboratories stock.
View analyst ratings for Core Laboratories
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2022?

3 brokers have issued 12-month target prices for Core Laboratories' shares. Their CLB stock forecasts range from $20.00 to $32.00. On average, they expect Core Laboratories' share price to reach $23.33 in the next year. This suggests a possible upside of 42.7% from the stock's current price.
View analysts' price targets for Core Laboratories
or view top-rated stocks among Wall Street analysts.

How has Core Laboratories' stock performed in 2022?

Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB shares have decreased by 26.7% and is now trading at $16.35.
View the best growth stocks for 2022 here
.

Are investors shorting Core Laboratories?

Core Laboratories saw a increase in short interest in July. As of July 15th, there was short interest totaling 5,170,000 shares, an increase of 25.8% from the June 30th total of 4,110,000 shares. Based on an average daily trading volume, of 457,700 shares, the days-to-cover ratio is currently 11.3 days. Approximately 11.2% of the company's stock are sold short.
View Core Laboratories' Short Interest
.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our earnings forecast for Core Laboratories
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its earnings results on Wednesday, July, 27th. The oil and gas company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by $0.02. The oil and gas company had revenue of $120.90 million for the quarter, compared to analyst estimates of $121.35 million. Core Laboratories had a trailing twelve-month return on equity of 16.12% and a net margin of 1.82%. Core Laboratories's revenue for the quarter was up 1.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.18 EPS.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Friday, July 29th. Stockholders of record on Monday, August 8th will be given a dividend of $0.01 per share on Monday, August 29th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date is Friday, August 5th.
View Core Laboratories' dividend history
.

Is Core Laboratories a good dividend stock?

Core Laboratories(NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.24%. The dividend payout ratio of Core Laboratories is 21.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.92% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of $0.13-$0.18 for the period, compared to the consensus estimate of $0.20. The company issued revenue guidance of $123.00 million-$129.00 million, compared to the consensus revenue estimate of $125.12 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (4.30%), Van ECK Associates Corp (4.14%), Douglas Lane & Associates LLC (1.19%), Congress Asset Management Co. MA (1.10%), Truist Financial Corp (0.91%) and Scout Investments Inc. (0.63%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories
.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $16.35.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $757.50 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.19 on an earnings per share basis.

How many employees does Core Laboratories have?

Core Laboratories employs 3,700 workers across the globe.

When was Core Laboratories founded?

Core Laboratories was founded in 1936.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for Core Laboratories is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.

This page (NYSE:CLB) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.